¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Smith degradation"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • degradation
    ºÐÇØ, ÅðÇà, ºØ±«
  • degradation product
    ºÐÇØ»ê¹°
  • fibrin degradation product
    ¼¶À¯¼ÒºÐÇØ»ê¹°, ÇǺ기ºÐÇØ»ê¹°
  • fibrinogen degradation products
    ¼¶À¯¼Ò¿øºÐÇØ»ê¹°
  • oxidative degradation
    »êÈ­ºÐÇØ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • degradation
    ºÐÇØ, ÅðÇà, ºØ±«
  • fibrinogen degradation products product
    ¼¶À¯¼ÒºÐÇØ»ê¹°
  • fibrinogen degradation products product
    ¼¶À¯¼Ò¿øºÐÇØ»ê¹°
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • degradation
    ºÐÇØ, ÅðÇà, ºØ±«
  • degradation product
    ºÐÇØ»ê¹°
  • oxidative degradation
    »êÈ­ºÐÇØ
  • fibrin degradation product
    ¼¶À¯¼ÒºÐÇØ»ê¹°
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Riley-Smith syndrome
    ¸±¸® ½º¹Ì½º ÁõÈıº
  • hephestic hemiplegia =smith s spasm
    ´ëÀåÀåÀÌÆí¸¶ºñ(¡­ø¶ Ýö), ´ëÀåÀå À̰æ·Ã.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hephestic hemiplegia =smith s spasm
    ´ëÀåÀåÀÌÆí¸¶ºñ(¡­ø¶ Ýö), ´ëÀåÀå À̰æ·Ã.
  • smith antigen
    ½º¹Ì½ºÇ׿ø(¡­ù÷ê«)
  • degradation
    ºØ±«
  • degradation
    ºÐÇØ, ÅðÇà.
  • degradation
    ºÐÇØ, ÅðÇà(÷Üú¼).
  • degradation product
    ºÐÇØ»ê¹°(ÝÂú°ß§Úª)
  • degradation senile
    ³ëÀμº ÅðÈ­.
  • fibrin degradation product
  • fibrin degradation products =fDP
    ¼¶À¯¼ÒºÐÇØ»ê¹°
  • fibrinogen degradation products=FDP
    ¼¶À¯¼Ò¿ø ºÐÇØ»ê¹°
  • oxidative degradation
    »êÈ­Àû ºÐÇØ(¹ÝÀÀ) (¡­ÝÂú°Úãëë).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Smith degradation
    ½º¹Ì½º ºÐÇØ(ÝÂú°)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • degradation
    ºÐÇØ(ÝÂú°)
  • detergent degradation
    "¼¼Á¦ºÐÇØ(á©ð¥ÝÂú°), (ÔÒ) biodegradable"
  • Edman degradation
    ¿¡µå¸¸ ºÐÇØ(ÝÂú°)
  • Fischer-MacDonald degradation
    ÇǼÅ-¸Æµµ³Îµå ºÐÇØ(ÝÂú°)
  • Ruff degradation
    ·çÇÁ ºÐÇØ(ÝÂú°)
  • subtractive Edman degradation
    Á¦°Å (ð¶ËÛ) ¿¡µå¸¸ºÐÇØ (ÝÂú°)
  • Wohl-Zemplen degradation
    º¼-ÁªÇ÷» ºÐÇØ (ÝÂú°)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • degradation
    ºÐÇØ, ÅðÇà
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
FDP fibrin degradation product; fibrinogen degradation product; flexor digitorum profundus; frontodextra...
PD Doctor of Pharmacy; Dublin Pharmacopoeia; interpupillary distance; Paget disease; pancreatic duct; p...
FDP(s)   1) Fibrinolytic split Products(= FSP)
  2) Fibrinogen Degradation Products
BGD blood group degradation
DP data processing; deep pulse; definitive procedure; degradation product; degree of polymerization; de...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
SLO Smith Lemli Opitz syndrome
SLOS Smith--Lemli--Opitz syndrome
SLO Smith-Lemli-Opitz
SMS Smith-Magenis Syndrome
FDP Fibrin Degradation Product
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • smith strang disease : ¸ÞŸÀÌ¿À´Ñ Èí¼ö Àå¾Ö¿¡ ÀÇÇÑ °ÍÀ¸·Î »ó¿°»öü¼º ¿­¼º ÇüÁú·Î À¯ÀüµÈ´Ù. È© °ÇÁ¶¼Ò³»ÀÇ ³¿»õ¿Í ºñ½ÁÇÑ Æ¯À¯ÇÑ ³¿»õ¸¦ ³»¸ç, À̰ÍÀº Èí¼öµÇÁö ¾ÊÀº ¸ÞŸÀÌ¿À´Ñ¿¡ ´ëÇÑ ¼¼±ÕÀÇ ÀÛ¿ë¿¡ ÀÇÇÏ¿© Á¶¼ºµÇ´Â ¾ËÆÄ ÇÏÀ̵å·Ï½Ã ³«»êÀÌ ¿øÀÎÀÌ´Ù.

    Smith's dis

    ½º¹Ì½º º´
  • degradation product
    ºÐÇØ »ê¹°
  • marginal degradation
    º¯¿¬ ºØ±«
  • Smith's operation
    ½º¹Ì½º ¼ö¼ú
  • Smith-Petersen nail
    ½º¹Ì½º-ÇÇÅͼ¾ ¸ø, ½º¹Ì½º-ÇÇÅͼ¾ Á¤
  • Smith-Pitfield stain
    ½º¹Ìµå-ÇÇÆ®ÇÇÀÏµå ¿°»ö¹ý
    Æí¸ðÀÇ ¿°»ö¹ýÀ¸·Î¼­, ¸Å¿° Àç·á´Â ¾Ï¸ð´Ï¾Æ ¸í¹ÝÀÇ Æ÷È­¾×°ú ½ÂÈ« Æ÷È­¾×À» È¥ÇÕÇÑ °Í¿¡ µî·®ÀÇ 10% ź´Ñ»ê¾×°ú ¹Ý·®ÀÇ 5% Ä«¸£º¼ÇªÅ©½Å ¾×À» ³Ö¾î¼­ ¸¸µé°í, À̰ÍÀ¸·Î ¸Å¿°ÇÑ ÈÄ Á¨Æ¼¾Æ´ÏÀÚ Æ÷È­ ¾ËÄÚ¿Ã ¿ë¾× 1¿ë°ú ¾Ï¸ð´Ï¾Æ ¸í¹Ý Æ÷È­¾× 10¿ëÀÇ ¿°»ö¾×À¸·Î ó¸®ÇÑ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
degradation <biochemistry, chemistry> The reduction of a chemical compound to one less complex, as by splitting off one or more groups.
(18 Nov 1997)
edman degradation A lab technique used to find out the order of amino acids in a polypeptide (chain of amino acids). It involves using the Edman reagent, phenyl isothiocyanate (PITC), to react one by one with each amino acid, in order. The technique is used in machines which automatically sequence (determine the order of subunits) polypeptides.
(09 Oct 1997)
fibrin degradation products <haematology, investigation> A test that measures fibrin degradation products which result from the dissolution of a blood clot.
Normal value is less than 10 mcg/ml (micrograms per millilitre).
They may be increased in conditions such as burns, placental abruption, heart disease, DIC, after massive blood transfusion, hypoxia, intrauterine foetal death, portacaval shunt, leukaemia, transfusion reaction, transplant rejection, sepsis, renal failure and preeclampsia.
Acronym: FDP
(23 Sep 2002)
fibrin fibrinogen degradation products <chemical> Soluble protein fragments formed by the proteolytic action of plasmin on fibrin or fibrinogen. Fdp and their complexes profoundly impair the haemostatic process and are a major cause of haemorrhage in intravascular coagulation and fibrinolysis.
Pharmacological action: antithrombins.
(12 Dec 1998)
Smith-Boyce operation An incision into the posterolateral renal parenchyma, gaining access to the calyceal system through an avascular plane between anterior and posterior branches of the renal artery; used for removal of calyceal and branched renal calculi, with maximum exposure yet minimal bleeding or parenchymal damage.
Synonym: Smith-Boyce operation.
(05 Mar 2000)
Smith, David <person> U.S. Paediatrician, *1926.
See: Smith-Lemli-Opitz syndrome.
(05 Mar 2000)
Smith, G <person> U.S. Neurosurgeon, 1917-1964.
See: Smith-Robinson operation.
(05 Mar 2000)
Smith, Henry <person> Irish born British military surgeon in India, 1862-1948.
See: Smith's operation, Smith-Indian operation.
(05 Mar 2000)
Smith-Indian operation A surgical technique for removal of cataract within the capsule.
Synonym: Smith's operation.
(05 Mar 2000)
smith-lemli-opitz syndrome <syndrome> Autosomal recessive disorder characterised by multiple congenital anomalies including microcephaly, mental retardation, unusual facies, and genital abnormalities. The biochemical defect is a lack of 7-dehydrocholesterol-delta-7-reductase, resulting in abnormally high levels of 7-dehydrocholesterol and low levels of cholesterol.
(12 Dec 1998)
Smith-Petersen, Marius <person> U.S. Surgeon, 1886-1953.
See: Smith-Petersen nail.
(05 Mar 2000)
Smith-Petersen nail A flanged nail for pinning a fracture of the neck of the femur.
(05 Mar 2000)
Smith-Riley syndrome <syndrome> Multiple haemangiomas, macrocephaly, and blurred optic disks; angiomas appear at birth or later, and enlarge and multiply.
(05 Mar 2000)
Smith, Robert <person> Irish surgeon, 1807-1873.
See: Smith's fracture.
(05 Mar 2000)
Smith-Robinson operation Interbody spinal fusion through an anterior cervical approach.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • smith
    ´ëÀåÀåÀÌ
  • degradation
    °ÝÇÏ;ÁÂõ;¸éÁ÷;Ÿ¶ô;ÀúÇÏ;ħ½Ä;ºÐÇØ
  • degradation
    ÁÂõ;ÆÄ¸é;Àú¶ô;Ç϶ô;Åðº¸
  • smith
    ´ëÀåÀåÀÌ;±Ý¼Ó¼¼°øÀå;Adam(1723-1790)¿µ±¹ÀÇ °æÁ¦ÇÐÀÚ;À±¸®ÇÐÀÚ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á